Original news and analysis on international IP policy
Por Tove Iren S. Gerhardsen Durante la reunión del Consejo Ejecutivo de la Organización Mundial de la Salud (OMS) celebrada entre el 22 y el 30 de enero, los Estados miembros expresaron consternación por el proceso del Grupo de Trabajo…
Par Tove Iren S. Gerhardsen Lors de la 120e session du conseil exécutif de l’Organisation mondiale de la santé (OMS), qui s’est tenue du 22 au 30 janvier, les Etats membres ont exprimé leurs inquiétudes vis-à-vis du processus engagé par…
By Tove Iren S. Gerhardsen At last week’s meeting of the World Health Organization (WHO) Executive Board, member states expressed dismay with the process of a public health and intellectual property working group and agreed that the spirit they set…
By Tove Iren S. Gerhardsen Non-governmental participants have different opinions about how a World Health Organization (WHO) working group set up to boost research and development into neglected diseases, should best move forward. While some argue that intellectual property rights…
By Tove Iren S. Gerhardsen A proposal at the World Health Organization (WHO) for early gains on a global plan for improving treatments for overlooked diseases has been tabled at a high-level meeting this week. Intellectual property rules are among…
By Jia Hepeng for Intellectual Property Watch BEIJING – The revision of a long-controversial rule on traditional Chinese medicine (TCM) is stranded amidst heated debates. While the government-led revision committee is analysing its stipulations for future implementation, some experts say…
By Tove Iren S. Gerhardsen
The year 2006 was a busy one in terms of health policy developments related to intellectual property rights, and a quick look at the events ahead in 2007 shows that the coming year should be no less interesting.
By William New In her opening remarks to staff on her first day in office, new World Health Organization Director-General Margaret Chan said she would not rock the organisation boat, would focus policy on women and Africa, issued a warning…
By Tove Iren S. Gerhardsen After Thailand issued a compulsory license for government production of an HIV/AIDS drug, the patent holder of the product, Merck Sharp & Dohme, has proposed reducing the price by almost two-thirds, local sources said. But…
Por Tove Iren S. Gerhardsen Durante una reunión celebrada del 4 al 8 de diciembre entre algunos de los 100 Estados miembros de la Organización Mundial de la Salud (OMS) y otras partes interesadas, se establecieron las bases de los…